Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05183880

Bioavailability of Orally Ingested Vitamin C

Investigating the Oral Bioavailability of Vitamin C Administered Using Phosphycell™ Technology - a Phosphatidylcholine-lipid Encapsulation Technology.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Exeter · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if crystalline vitamin C supplementation can acutely increase skeletal muscle vitamin C concentrations and if this can be potentiated by administering vitamin C using Phosphycell™ Technology - a phosphatidylcholine-lipid encapsulation technology.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPhosphatidylcholine-lipid encapsulated vitamin CIngesting 1000 mg of vitamin C in phosphatidylcholine-lipid encapsulated form
DIETARY_SUPPLEMENTCrystalline vitamin CIngesting 1000 mg of vitamin C in crystalline form

Timeline

Start date
2021-11-26
Primary completion
2022-11-26
Completion
2023-11-26
First posted
2022-01-11
Last updated
2024-05-16

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05183880. Inclusion in this directory is not an endorsement.